571-765-7700
Federal Circuit Shoots Down District Court’s Claim Construction
|
Claim requiring removal of element can include that same element in infringing product
Judge Albright Grants § 101 Summary Judgment Motion
|
In a rare decision, Western District of Texas court holds patent invalid under § 101
Negative Claim Limitation Finds Support in Patent
|
Federal Circuit states there is no heightened written description standard for negative limitations
Federal Circuit Remands Intel IPRs Back to USPTO
|
Intel’s challenges to Qualcomm’s patents sent back to the USPTO to resolve claim interpretation and obviousness issues
Federal Circuit Places Limits on Numerical Amount in Patent Claim
|
Interpreting a numerical claim limitation requires examining the specification and prosecution history, rather than acontextually performing a significant digits analysis
Trying Combination Disclosed by Prior Art Results in Patent
|
The patentee tried a combination as directed by the prior art and obtained a patent on the combination. The Federal Circuit upheld the patent because the prior art did not show a reasonable expectation of success.
Moderna’s COVID-19 Vaccine May Infringe Valid Patent
|
After holding Moderna has standing to appeal an adverse Inter Partes Review decision, Federal Circuit upholds patent over Moderna’s challenge. Concerning another adverse decision in an IPR against a different patent, Moderna found not to have standing to appeal.
Examiners Not Likely to Even Answer PTAB Appeal Briefs
|
Many PTAB appeal briefs are not answered by the Examining Corps, thereby leading to favorable results for the patent applicants
MS Treatment Patent Invalid for Lack of Written Description
|
The patent specification did not support a claim to a specific dose of 480 mg/day of DMF, sold under the brand name Tecfidera for the treatment of MS
Federal Circuit Affirms PTAB Decision Finding Claimed Amount Had Written Description Support and Claimed Ranges Did Not
|
Held: Written description cases are intensively fact-oriented and a disclosure with isolated examples does not support claimed ranges with lower and upper bounds
1 2 3
Federal Circuit Shoots Down District Court’s Claim Construction
|
Claim requiring removal of element can include that same element in infringing product
Judge Albright Grants § 101 Summary Judgment Motion
|
In a rare decision, Western District of Texas court holds patent invalid under § 101
Negative Claim Limitation Finds Support in Patent
|
Federal Circuit states there is no heightened written description standard for negative limitations
Federal Circuit Remands Intel IPRs Back to USPTO
|
Intel’s challenges to Qualcomm’s patents sent back to the USPTO to resolve claim interpretation and obviousness issues
Federal Circuit Places Limits on Numerical Amount in Patent Claim
|
Interpreting a numerical claim limitation requires examining the specification and prosecution history, rather than acontextually performing a significant digits analysis
Trying Combination Disclosed by Prior Art Results in Patent
|
The patentee tried a combination as directed by the prior art and obtained a patent on the combination. The Federal Circuit upheld the patent because the prior art did not show a reasonable expectation of success.
Moderna’s COVID-19 Vaccine May Infringe Valid Patent
|
After holding Moderna has standing to appeal an adverse Inter Partes Review decision, Federal Circuit upholds patent over Moderna’s challenge. Concerning another adverse decision in an IPR against a different patent, Moderna found not to have standing to appeal.
Examiners Not Likely to Even Answer PTAB Appeal Briefs
|
Many PTAB appeal briefs are not answered by the Examining Corps, thereby leading to favorable results for the patent applicants
MS Treatment Patent Invalid for Lack of Written Description
|
The patent specification did not support a claim to a specific dose of 480 mg/day of DMF, sold under the brand name Tecfidera for the treatment of MS
Federal Circuit Affirms PTAB Decision Finding Claimed Amount Had Written Description Support and Claimed Ranges Did Not
|
Held: Written description cases are intensively fact-oriented and a disclosure with isolated examples does not support claimed ranges with lower and upper bounds
1 2 3
Look Around the Archives